Latest news
Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:20 GMTCorbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:30:00 GMTObesity Treatment Study Reaches Final Visit; Corbus Data Expected in September - Stock TitanStock Titan · Tue, 04 Aug 2026 12:30:00 GMT